scispace - formally typeset
M

Marla L. Clayman

Researcher at American Institutes for Research

Publications -  86
Citations -  4873

Marla L. Clayman is an academic researcher from American Institutes for Research. The author has contributed to research in topics: Patient participation & Oncofertility. The author has an hindex of 31, co-authored 79 publications receiving 4215 citations. Previous affiliations of Marla L. Clayman include University of South Florida & Northwestern University.

Papers
More filters
Journal ArticleDOI

Measuring patients’ self-efficacy in understanding and using prescription medication

TL;DR: The MUSE is an effective and brief research tool that can be utilized among participants with varying literacy levels and differs from existing medication-specific self-efficacy scales as it addresses both learning about one's medications and adherence to the prescribed regimen.
Journal ArticleDOI

Patient-centered approach for improving prescription drug warning labels.

TL;DR: A patient-centered approach to designing consumer medication information could improve the comprehensibility of existing warning labels, particularly among patients with limited literacy.
Journal ArticleDOI

Providing information about options in patient decision aids.

TL;DR: It appears that PtDAs result in patients having higher knowledge scores and in reduced feelings of being uninformed over patients who receive usual care, but the differences are small and can be reversed under some circumstances.
Journal ArticleDOI

Communicating About Chemotherapy-Induced Nausea and Vomiting: A Comparison of Patient and Provider Perspectives

TL;DR: Patients' and providers' perceptions of management and barriers to quality CINV care are identified and misconceptions and establishing mutually consistent goals will lead to more effective overall care are addressed.
Journal ArticleDOI

Development of a shared decision making coding system for analysis of patient-healthcare provider encounters.

TL;DR: DEEP-SDM facilitates content analysis of encounters between women with metastatic breast cancer and their medical oncologists and helps inform the relationship of SDM to patient-reported outcomes.